[go: up one dir, main page]

IL109509A0 - Transdermal system containing an indole derivative and a process for the preparation thereof - Google Patents

Transdermal system containing an indole derivative and a process for the preparation thereof

Info

Publication number
IL109509A0
IL109509A0 IL10950994A IL10950994A IL109509A0 IL 109509 A0 IL109509 A0 IL 109509A0 IL 10950994 A IL10950994 A IL 10950994A IL 10950994 A IL10950994 A IL 10950994A IL 109509 A0 IL109509 A0 IL 109509A0
Authority
IL
Israel
Prior art keywords
preparation
system containing
indole derivative
transdermal system
active substances
Prior art date
Application number
IL10950994A
Other versions
IL109509A (en
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL109509A0 publication Critical patent/IL109509A0/en
Publication of IL109509A publication Critical patent/IL109509A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention concerns a transdermal therapeutic system for the systemic administration of active substances, the system being characterized in that at least one of the active substances is a serotonin agonist selected from the indole derivatives, e.g. sumatriptan.
IL10950994A 1993-05-06 1994-05-02 Transdermal system containing an indole derivative and a process for the preparation thereof IL109509A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4314976A DE4314976C1 (en) 1993-05-06 1993-05-06 Transdermal therapeutic systems for the administration of drugs, process for their production and their use

Publications (2)

Publication Number Publication Date
IL109509A0 true IL109509A0 (en) 1994-08-26
IL109509A IL109509A (en) 1999-12-22

Family

ID=6487316

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10950994A IL109509A (en) 1993-05-06 1994-05-02 Transdermal system containing an indole derivative and a process for the preparation thereof

Country Status (20)

Country Link
EP (1) EP0697869B1 (en)
JP (1) JPH08509749A (en)
KR (1) KR960702306A (en)
AT (1) ATE183392T1 (en)
AU (1) AU686159B2 (en)
CA (1) CA2160776A1 (en)
CZ (1) CZ289395A3 (en)
DE (2) DE4314976C1 (en)
DK (1) DK0697869T3 (en)
ES (1) ES2138659T3 (en)
FI (1) FI955260A7 (en)
GR (1) GR3031639T3 (en)
HU (1) HUT74865A (en)
IL (1) IL109509A (en)
NO (1) NO954414L (en)
NZ (1) NZ265949A (en)
PL (1) PL179353B1 (en)
SK (1) SK138095A3 (en)
WO (1) WO1994026270A1 (en)
ZA (1) ZA942872B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4467396A (en) * 1994-12-12 1996-07-10 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
WO2001043736A1 (en) * 1999-12-14 2001-06-21 Teikoku Seiyaku Co., Ltd. Drugs for relieving hemicrania
ATE404193T1 (en) * 2001-06-05 2008-08-15 Ronald Aung-Din TOPICAL MIGRAINE THERAPY
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
EP1575566B1 (en) 2002-12-26 2012-02-22 Pozen, Inc. Multilayer dosage forms containing naproxen and triptans
CA2529528A1 (en) 2003-06-20 2004-12-29 Ronald Aung-Din Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
EA200801369A1 (en) * 2005-12-20 2009-02-27 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. METHODS OF TRANSDERMAL ADMINISTRATION OF THE INDONSEROTONIN RECEPTOR AGONIST AND TRANSDERMAL DOSAGE FORM FOR USE OF THIS METHOD
BRPI0709965C2 (en) 2006-04-13 2011-12-20 Nupathe Inc improved polyamine formulations for tryptan iontophoresis
WO2010005507A1 (en) 2008-06-30 2010-01-14 Afgin Pharma, Llc Topical regional neuro-affective therapy
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
US9211282B2 (en) 2009-09-25 2015-12-15 Dr. Reddy's Laboratories Ltd. Formulations comprising triptan compounds
JP6216151B2 (en) * 2013-04-19 2017-10-18 コスメディ製薬株式会社 Hydrophilic drug emulsion patch
AU2016226267A1 (en) 2015-03-02 2017-09-28 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoids
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
AU8072691A (en) * 1990-06-28 1992-01-23 Beecham Group Plc Pharmaceutical preparations
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions

Also Published As

Publication number Publication date
HUT74865A (en) 1997-02-28
NO954414D0 (en) 1995-11-03
DE59408643D1 (en) 1999-09-23
AU6648094A (en) 1994-12-12
EP0697869B1 (en) 1999-08-18
ZA942872B (en) 1995-07-06
KR960702306A (en) 1996-04-27
FI955260A0 (en) 1995-11-02
PL179353B1 (en) 2000-08-31
NZ265949A (en) 1997-10-24
CA2160776A1 (en) 1994-11-24
HU9503167D0 (en) 1996-01-29
DE4314976C1 (en) 1994-10-06
AU686159B2 (en) 1998-02-05
ES2138659T3 (en) 2000-01-16
NO954414L (en) 1995-11-03
FI955260L (en) 1995-11-17
DK0697869T3 (en) 2000-03-20
GR3031639T3 (en) 2000-02-29
SK138095A3 (en) 1996-06-05
FI955260A7 (en) 1995-11-17
JPH08509749A (en) 1996-10-15
CZ289395A3 (en) 1996-04-17
WO1994026270A1 (en) 1994-11-24
EP0697869A1 (en) 1996-02-28
IL109509A (en) 1999-12-22
PL311591A1 (en) 1996-02-19
ATE183392T1 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
IL109509A (en) Transdermal system containing an indole derivative and a process for the preparation thereof
NO994706L (en) Pharmaceutical composition for oral administration of an N-piperidino-3-pyrazole carboxyamide derivative, as well as salts and solvates thereof
AU5106890A (en) Device for the transdermal delivery of nicotine
NZ236002A (en) Transdermal delivery system for 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
ZA928011B (en) Transdermal administration of melatonin.
PL331709A1 (en) Cytotoxic aminosaccharic and affinite saccharic derivatives of indolopyrrole carbazoles
AU2293992A (en) Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders
IL106737A0 (en) Indole and indoline derivatives, process for their preparation and use as medicament
YU31492A (en) HETEROCYCLIC-4-AMINO-1,3,4,5-TETRAHYDROBENZE [CD] INDOLES
EP0369685A3 (en) Fluoxetine analog
ZA963743B (en) Transdermal therapeutic system (TTS) for the administration of testosterone
ZA968905B (en) Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
GEP20063719B (en) Prevention of Migraine Recurrence
MX9708394A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation.
AU5103196A (en) Form of administration for applying pharmaceutical substances and auxiliary substances, and process for the preparation thereof
CA2135710A1 (en) Melatonin derivatives for use in treating desynchronization disorders
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
ZA963744B (en) Topical aciclovir preparation
FI811889A7 (en) Process for the preparation of pharmaceutically active indole and indoline derivatives.
DE3778165D1 (en)
NO931208L (en) FORMULATIONS FOR TRANSDERMAL CONTRASE OPTIVES, AND PROCEDURES AND DEVICES FOR SUPPLYING SUCH
SI0697869T1 (en) Transdermal therapeutic systems for the administration of serotonin agonists
IT1258803B (en) Pharmaceutical compositions comprising melatonin or one of its agonist derivatives suitable for the treatment of cerebrovascular disorders
AU3726193A (en) Methods and apparatus for drug delivery using supercritical solutions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees